首页> 美国卫生研究院文献>Journal of Lifestyle Medicine >Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol ( 14 mmol/L) and Triglycerides ( 40 mmol/L)
【2h】

Use of Lifestyle Modifications for Management of a Patient with Severely High Total Cholesterol ( 14 mmol/L) and Triglycerides ( 40 mmol/L)

机译:使用生活方式改性用于管理严重高胆固醇( 14mmol / L)和甘油三酯( 40mmol / L)的患者

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this report, we describe a case of a 37-year old man who presented with a history of total cholesterol > 14 mmol/L and triglyceride levels > 40 mmol/L. The patient was initially thought to have familial hypercholesterolemia due to his elevated total cholesterol, by his family physician. He was prescribed evolucumab, a proprotein convertase subtilisin/ kexin type 9 inhibitor drug which has shown efficacy for lowering low-density lipoprotein-cholesterol levels, to reduce his high total cholesterol. However, in this patient, the elevated total cholesterol was likely due to hypertriglyceridemia, rather than increased low-density lipoprotein-cholesterol levels. Through this case we provide an approach for the clinical management of patients with elevated total cholesterol with underlying triglycerides ≥ 10 mmol/L. The primary intervention for management of triglycerides ≥ 10 mmol/L involves lifestyle modifications including, changes in diet, exercise, reduction in body mass index, and abstinence from alcohol consumption. Secondary intervention involves management through pharmacotherapy with fibrates and statins. Creating a plan of action with the patient, incorporating lifestyle modifications alone, the patient was able to reduce the triglycerides from an average of 44.94 mmol/L to 3.28 mmol/L.
机译:在本报告中,我们描述了一个37岁的男子患者,患有总胆固醇的历史> 14 mmol / L和甘油三酯水平> 40 mmol / L.由于他的家庭医生,患者最初被认为具有家族性高胆固醇血症。他被规定的Evolucumab,Proprotein转化酶枯草杆菌蛋白酶/ kexin型9抑制剂药物,其显示出降低低密度脂蛋白 - 胆固醇水平的功效,以减少他的高总胆固醇。然而,在该患者中,升高的总胆固醇可能是由于高甘油脂血症,而不是增加低密度脂蛋白 - 胆固醇水平。通过这种情况,我们提供了一种患者肝脏升高的蛋白质蛋白质≥10mmol/升的患者临床管理方法。甘油三酯≥10mmol/ L管理的主要干预涉及生活方式修改,包括饮食,运动,体重指数的变化,以及饮料消费的禁欲。二次干预涉及通过匹配敌人和他汀类药物的药物治疗来管理。与患者创建一个行动计划,单独掺入生活方式修饰,患者能够将甘油三酯的平均值降低至3.28mmol / L.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号